Sunesis Pharmaceuticals - 48 Year Dividend Yield History | SNSS

Historical dividend payout and yield for Sunesis Pharmaceuticals (SNSS) since 1971. The current TTM dividend payout for Sunesis Pharmaceuticals (SNSS) as of February 20, 2019 is $0.00. The current dividend yield for Sunesis Pharmaceuticals as of February 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.001B
Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. It has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. It is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Bio-Techne Corp (TECH) United States $7.246B 48.82